BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25765526)

  • 1. Normal liver sparing by proton beam therapy for hepatocellular carcinoma: Comparison with helical intensity modulated radiotherapy and volumetric modulated arc therapy.
    Kim JY; Lim YK; Kim TH; Cho KH; Choi SH; Jeong H; Kim DW; Park JH; Shin DH; Lee SB; Kim SS; Kim JY; Kim DY; Park JW
    Acta Oncol; 2015 Nov; 54(10):1827-32. PubMed ID: 25765526
    [No Abstract]   [Full Text] [Related]  

  • 2. Superior liver sparing by combined coplanar/noncoplanar volumetric-modulated arc therapy for hepatocellular carcinoma: a planning and feasibility study.
    Tsai YC; Tsai CL; Hsu FM; Jian-Kuen W; Chien-Jang W; Cheng JC
    Med Dosim; 2013; 38(4):366-71. PubMed ID: 23769922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of the optimal radiotherapy technique for locally advanced hepatocellular carcinoma.
    Lee IJ; Seong J; Koom WS; Kim YB; Jeon BC; Kim JH; Han KH
    Jpn J Clin Oncol; 2011 Jul; 41(7):882-9. PubMed ID: 21515609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapy.
    Song JH; Son SH; Kay CS; Jang HS
    Oncotarget; 2015 Oct; 6(32):33952-60. PubMed ID: 26376679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative dosimetry of volumetric modulated arc therapy and limited-angle static intensity-modulated radiation therapy for early-stage larynx cancer.
    Riegel AC; Antone J; Schwartz DL
    Med Dosim; 2013; 38(1):66-9. PubMed ID: 22901745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton therapy in clinical practice.
    Liu H; Chang JY
    Chin J Cancer; 2011 May; 30(5):315-26. PubMed ID: 21527064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional conformal radiation therapy and intensity-modulated radiation therapy combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma: an irradiation dose escalation study.
    Ren ZG; Zhao JD; Gu K; Chen Z; Lin JH; Xu ZY; Hu WG; Zhou ZH; Liu LM; Jiang GL
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):496-502. PubMed ID: 20421145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours.
    Petersen JB; Lassen Y; Hansen AT; Muren LP; Grau C; Høyer M
    Acta Oncol; 2011 Aug; 50(6):823-8. PubMed ID: 21767180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of External Beam Radiotherapy in Hepatocellular Carcinoma.
    Chen CP
    Clin Liver Dis; 2020 Nov; 24(4):701-717. PubMed ID: 33012454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rolling stones: An inappropriate surrogate for upper-abdominal image-guided radiation therapy.
    Chen J; Murray L; Dawson LA; Velec M
    Pract Radiat Oncol; 2018; 8(6):369-372. PubMed ID: 29706303
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stereotactic body radiation therapy in the management of liver tumours].
    Jacob J; Nguyen F; Deutsch E; Mornex F
    Cancer Radiother; 2014 Oct; 18(5-6):486-94. PubMed ID: 25195113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial.
    Bush DA; Kayali Z; Grove R; Slater JD
    Cancer; 2011 Jul; 117(13):3053-9. PubMed ID: 21264826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
    Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases.
    Jang JW; Kay CS; You CR; Kim CW; Bae SH; Choi JY; Yoon SK; Han CW; Jung HS; Choi IB
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):412-8. PubMed ID: 18963538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformal and stereotactic radiotherapy in hepatocellular carcinoma.
    Scorsetti M; Bignardi M
    Ann Ital Chir; 2008; 79(2):107-10. PubMed ID: 18727272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma.
    Kawashima M; Kohno R; Nakachi K; Nishio T; Mitsunaga S; Ikeda M; Konishi M; Takahashi S; Gotohda N; Arahira S; Zenda S; Ogino T; Kinoshita T
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1479-86. PubMed ID: 20605350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma.
    Taddei PJ; Howell RM; Krishnan S; Scarboro SB; Mirkovic D; Newhauser WD
    Phys Med Biol; 2010 Dec; 55(23):7055-65. PubMed ID: 21076199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy.
    Horn S; Fournier-Bidoz N; Pernin V; Peurien D; Vaillant M; Dendale R; Fourquet A; Kirova YM
    Cancer Radiother; 2016 Apr; 20(2):98-103. PubMed ID: 26992750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.